Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study.
Searles
Gordon
G
Keystone Dermatology Institute, Edmonton, AB. gesearles@mac.com
Bissonnette
Robert
R
Landells
Ian
I
Shear
Neil H
NH
D000077944:Alefacept; D002170:Canada / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D009017:Morbidity / Q000639:trends; D011565:Psoriasis / Q000188:drug therapy* / Q000453:epidemiology; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome
D003879:Dermatologic Agents; D011993:Recombinant Fusion Proteins; D000077944:Alefacept